Androgen-independent Prostate Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2010-10-11
Clinical Trial Update: Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442) [Phase 2]
Phase 2 trial update for immunotherapy in men with metastatic androgen independent prostate cancer (D9902 Part B).